$995.00 per attendee or per site (Non-Member Price)
$545.00 per attendee or per site (SCRS members)
This price is for you, or your whole site!
Not an SCRS member? Join now to attend this webinar at the member price.
In today’s environment of increased regulatory compliance, decreasing economics, and growing competition, investigative sites are faced with greater and more complex site management objectives. Often sites are being asked to assume more and more tasks without adequate remuneration. As a result, sites are generating modest to no operating profits as they absorb these “hidden costs” of conducting and providing quality research.
Your fee covers these four 60-minute modules and access to the recordings until July 30, 2023
Contact Hours: 1 Contact Hour will be issued for each session.
Contact hours are not issued for viewing recorded presentations.
We will send the link and slides a few hours prior to each presentation.
Session 1: The Truth Behind the Financial Impact of Decentralized Clinical Trials
March 28, 2023 at 12:00 pm ET
Speakers:
Meghan Harrington, VP Clinical Trial Financial Management, Medidata
Cris McDavid, Director, Global Clinical Operations, Parexel
James Brazeal, VP Research Operations, Circuit Clinical
Nadia Aldhalimy, Regional Manager, Circuit Clinical
The impacts of decentralized trials on clinical financial management are becoming clearer as more sites, sponsors, and CROs execute virtual and hybrid trials. Measuring data is key to understanding the difference between perception and reality on the impact of DCTs, but does the industry have enough cost benchmarking data to make conclusions and respond accordingly? Join this panel session as a site, sponsor, and CRO share the effects of remote monitoring and the shift from SDV to SDR, hidden costs on DCTs, and the extra time that sites spend supporting patients with technology.
Objectives:
- Illustrate how algorithms in the industry around costing benchmarks take into account remote/ virtual visits
- Discuss unique financial challenges sites are facing that could affect the patient experience
- Interpret how to reimagine financial stability and planning for decentralized clinical trials
Session 2: Best Practices for Contract Development & Negotiations
April 25, 2023 at 12:00 pm ET
Speaker: Carolina Hewell, Esq., Associate Director, Clinical Operations Manager-Finance, Merck
The negotiation of a clinical trials budget is a time-consuming and often daunting task for sponsors and sites. Budget negotiation delays can have negative financial impacts, creating frustration and loss of goodwill. Additionally, inaccurate budgets can result in astronomical financial losses for both sides. Join this panel of experts as they discuss best practices for contact development and how to negotiate fair and comprehensive budgets.
Objectives:
- Discover ways to better develop site level contracts and clauses.
- Take best practices associated with contract and budget negotiation back to your site
- Learn how to better protect your site from potential financial loss
Session 3: Determining Costs & Pricing: Techniques for Mastering Skillful Trial Planning
May 9, 2023 at 12:00 pm ET
Speaker: Erin Williams, Vice President, Contracts and Regulatory, Velocity Clinical Research
Understanding the true cost of something is essential when making a financial for your business. However, the true cost may not always be simple to calculate. The same is true when conducting clinical trials. After the sponsor has selected a site to participate in the trial, one must understand the overall cost of the study to determine if conducting the study is feasible. This webinar will cover the essential tools needed to assess costs and prices of conducting a study as well as techniques to help in feasibility and planning.
Objectives:
- Discover essential tools to assess costs
- Take best techniques to help in feasibility and planning for costs of trials
- Learn how to better discover costs associated with a study
Session 4: Fixed & Hidden Costs: Overview, Examples & Applications
May 30, 2023 at 12:00 pm ET
Speakers:
David Vulcano, Vice President, Research Compliance & Integrity, HCA Healthcare
Chris Hoyle, CEO & Founder, Elite Research Network
Casey Orvin, Chief Commercial Officer, CenExel Centers of Excellence
A proper clinical trial budget is one that not only factors in the obvious costs, but also anticipates hidden ones and provides for unexpected situations or contingencies. Join our expert panel as they discuss fixed and hidden costs, the impact of changes to scope, as well as examples of best practices for budgeting at a site.
Objectives:
- Comprehend examples of hidden costs that exist in a contract and budget
- Learn about what the common hidden costs are in a trial budget
- Best practices for budgeting as a site
----------------------